The interleukin 17 system in cortical lesions in focal cortical dysplasias.
about
The search for circulating epilepsy biomarkersTargeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approachesIntratumor IL-17-positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients.Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouseDownregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.Epileptic seizures as a manifestation of cow's milk allergy: a studied relationship and description of our pediatric experience.The role of IL-17 in CNS diseases.Disease modification in epilepsy: from animal models to clinical applications.Inflammation in Epileptic Encephalopathies.Maternal IL-17A in autism.Acute treatment with minocycline, but not valproic acid, improves long-term behavioral outcomes in the Theiler's virus model of temporal lobe epilepsy.Increased expression of TRPC5 in cortical lesions of the focal cortical dysplasia.Interictal interleukin-17A levels are elevated and correlate with seizure severity of epilepsy patients.TLR1 expression in mouse brain was increased in a KA-induced seizure model.Brain infection with Staphylococcus aureus leads to high extracellular levels of glutamate, aspartate, γ-aminobutyric acid, and zinc.Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy.
P2860
Q26851663-B7E85662-5A62-42D7-8A35-CFC159D890DAQ27009518-50395FDB-0485-4693-A99F-7023402D4011Q34149842-E527E173-0734-4D8F-ACE8-E9B778661AE1Q35531800-19B2B7E3-4DBD-418D-9576-1AA23C9E0BF7Q36815367-893851BF-1C6C-46BE-B394-1E21E9874A91Q37701698-AEACE16E-5CE7-4710-BFFD-7473135B2B84Q38268004-1751B5CF-92F8-4E50-A43A-2D64BE68DC1BQ38365272-06C55ADE-9541-4153-B7A2-310DE71B42C6Q38450069-A0E55312-933A-4911-A90A-7FE7EC7327BFQ38692603-C07DB3AB-F7C6-4132-B52E-A6BDB6EAC597Q39271108-CA67C7EF-2307-4726-93F3-C704A3BAB4B1Q40507200-3E92CA73-938D-4AD8-84CE-2AD82AEC1A37Q43799375-67626CA6-213F-4D13-A779-C2993BA7EBBFQ46834483-D832C834-1CFE-4964-A849-74794D27CA08Q48155386-8F20C70C-0CD1-4DB3-B224-ADD023DA74E8Q48648776-10B53A1F-595D-4DA6-92E5-C716252DCDD4Q50533963-986618C8-AD06-4445-AED4-7C1DCF3ADD5C
P2860
The interleukin 17 system in cortical lesions in focal cortical dysplasias.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The interleukin 17 system in cortical lesions in focal cortical dysplasias.
@en
The interleukin 17 system in cortical lesions in focal cortical dysplasias.
@nl
type
label
The interleukin 17 system in cortical lesions in focal cortical dysplasias.
@en
The interleukin 17 system in cortical lesions in focal cortical dysplasias.
@nl
prefLabel
The interleukin 17 system in cortical lesions in focal cortical dysplasias.
@en
The interleukin 17 system in cortical lesions in focal cortical dysplasias.
@nl
P2093
P2860
P1476
The interleukin 17 system in cortical lesions in focal cortical dysplasias.
@en
P2093
Hai-Feng Shu
Jiao-Jiang He
Shi-Yong Liu
P2860
P304
P356
10.1097/NEN.0B013E318281262E
P577
2013-02-01T00:00:00Z